We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights Novo Nordisk, Suncor Energy, Nasdaq, W.W. Grainger and Textron
Read MoreHide Full Article
For Immediate Release
Chicago, IL – October 3, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Novo Nordisk A/S (NVO - Free Report) , Suncor Energy Inc. (SU - Free Report) , Nasdaq, Inc. (NDAQ - Free Report) , W.W. Grainger, Inc. (GWW - Free Report) and Textron Inc. (TXT - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Analyst Reports for Novo Nordisk, Suncor and Nasdaq
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Novo Nordisk A/S, Suncor Energy Inc. and Nasdaq, Inc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Novo Nordisk shares have underperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+4.7% vs. +7.1%). The Zacks analyst believes that lower realized prices in the United States, loss of exclusivity for products and stiff competition are affecting the company's sales. Sales are also being negatively impacted by the COVID-19 pandemic. The supply challenges for Wegovy have impacted the stock. The patent expiry on some of the products in Novo Nordisk’s portfolio remains a woe.
However, the promising diabetes drug, Ozempic, is off to a solid start since its launch. The drug remains the growth engine for the company. The launch of Rybelsus also looks impressive. Novo Nordisk has one of the broadest diabetes portfolios in the industry. Drug sales have been gaining and maintaining momentum.
Suncor Energy’s shares have advanced +35.1% over the past year against the Zacks Oil and Gas - Integrated - Canadian industry’s gain of +42.8%. The Zacks analyst believes that the company has an impressive supply chain network, owning significant oil sands and conventional production platforms, along with a strong downstream portfolio. Suncor Energy is one of the best positioned companies in the energy space given its access to abundant resources, rich operating experience and technical know-how. Suncor Energy's major projects, including Fort Hills and Syncrude, should support its growth momentum.
The company's strong liquidity and modest near-term debt maturities are other positives. Moreover, Suncor Energy plans to maintain a disciplined capital approach and estimates to repay further debt in 2022, thereby indicating its ability to generate cash flow.
Nasdaq shares have outperformed the Zacks Securities and Exchanges industry over the past three-month period (+10.1% vs. -4.4%). The Zacks analyst believes that the company has been successful in maximizing opportunities as a technology and analytics provider and growing core marketplace businesses. Focus on growth via acquisitions and organic initiatives, which aided its entry into new markets and helped it gain cross-selling opportunities, bodes well. Intense focus on Market Technology and Information Services businesses also helps the company to explore vast opportunities per its developmental strategies.
Nasdaq remains committed to deploy capital effectively by investing in organic growth initiatives. Its board announced a three-for-one stock split in the form of a stock dividend. However, high expenses weigh on margin expansion. High leverage ratio poses risk.
Other noteworthy reports we are featuring today include W.W. Grainger, Inc. and Textron Inc.
Why Haven’t You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
The Zacks Analyst Blog Highlights Novo Nordisk, Suncor Energy, Nasdaq, W.W. Grainger and Textron
For Immediate Release
Chicago, IL – October 3, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Novo Nordisk A/S (NVO - Free Report) , Suncor Energy Inc. (SU - Free Report) , Nasdaq, Inc. (NDAQ - Free Report) , W.W. Grainger, Inc. (GWW - Free Report) and Textron Inc. (TXT - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Analyst Reports for Novo Nordisk, Suncor and Nasdaq
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Novo Nordisk A/S, Suncor Energy Inc. and Nasdaq, Inc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Novo Nordisk shares have underperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+4.7% vs. +7.1%). The Zacks analyst believes that lower realized prices in the United States, loss of exclusivity for products and stiff competition are affecting the company's sales. Sales are also being negatively impacted by the COVID-19 pandemic. The supply challenges for Wegovy have impacted the stock. The patent expiry on some of the products in Novo Nordisk’s portfolio remains a woe.
However, the promising diabetes drug, Ozempic, is off to a solid start since its launch. The drug remains the growth engine for the company. The launch of Rybelsus also looks impressive. Novo Nordisk has one of the broadest diabetes portfolios in the industry. Drug sales have been gaining and maintaining momentum.
(You can read the full research report on Novo Nordisk here >>>)
Suncor Energy’s shares have advanced +35.1% over the past year against the Zacks Oil and Gas - Integrated - Canadian industry’s gain of +42.8%. The Zacks analyst believes that the company has an impressive supply chain network, owning significant oil sands and conventional production platforms, along with a strong downstream portfolio. Suncor Energy is one of the best positioned companies in the energy space given its access to abundant resources, rich operating experience and technical know-how. Suncor Energy's major projects, including Fort Hills and Syncrude, should support its growth momentum.
The company's strong liquidity and modest near-term debt maturities are other positives. Moreover, Suncor Energy plans to maintain a disciplined capital approach and estimates to repay further debt in 2022, thereby indicating its ability to generate cash flow.
(You can read the full research report on Suncor Energy here >>>)
Nasdaq shares have outperformed the Zacks Securities and Exchanges industry over the past three-month period (+10.1% vs. -4.4%). The Zacks analyst believes that the company has been successful in maximizing opportunities as a technology and analytics provider and growing core marketplace businesses. Focus on growth via acquisitions and organic initiatives, which aided its entry into new markets and helped it gain cross-selling opportunities, bodes well. Intense focus on Market Technology and Information Services businesses also helps the company to explore vast opportunities per its developmental strategies.
Nasdaq remains committed to deploy capital effectively by investing in organic growth initiatives. Its board announced a three-for-one stock split in the form of a stock dividend. However, high expenses weigh on margin expansion. High leverage ratio poses risk.
(You can read the full research report on Nasdaq here >>>)
Other noteworthy reports we are featuring today include W.W. Grainger, Inc. and Textron Inc.
Why Haven’t You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.